Efficacy and safety of the novel HER3 directed antibody drug conjugate patritumab deruxtecan (HER3-DXd; U3-1402) in EGFR-mutated NSCLC Meeting Abstract
| Authors: | Yu, H.; Baik, C.; Gold, K.; Hayashi, H.; Johnson, M.; Koczywas, M.; Murakami, H.; Nishio, M.; Steuer, C.; Su, W.; Yang, J. C.; Karam, S.; Qi, Z.; Qiu, Y.; Chen, S.; Yu, C.; Janne, P. |
| Abstract Title: | Efficacy and safety of the novel HER3 directed antibody drug conjugate patritumab deruxtecan (HER3-DXd; U3-1402) in EGFR-mutated NSCLC |
| Meeting Title: | 2020 World Conference on Lung Cancer |
| Keywords: | nsclc; her3; antibody drug conjugate |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 16 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 28-31 |
| Meeting Location: | Singapore |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-03-01 |
| Start Page: | S107 |
| Language: | English |
| ACCESSION: | WOS:000631349600081 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2021.01.281 |
| Notes: | Meeting Abstract: OA03.04 -- Due to Covid-19 pandemic, the conference was held virtually -- Source: Wos |
